The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. ObsEva's Revenue for the
three
months ended in Dec. 2022 was $19.64 Mil. ObsEva's average Accounts Receivable for the
three
months ended in Dec. 2022 was $0.25 Mil.
Hence, ObsEva's Receivables Turnover for the
three
months ended in Dec. 2022 was 77.92.
ObsEva Receivables Turnover Historical Data
The historical data trend for ObsEva's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ObsEva's Receivables Turnover
For the Biotechnology subindustry, ObsEva's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ObsEva's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ObsEva's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where ObsEva's Receivables Turnover falls into.
ObsEva Receivables Turnover Calculation
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
ObsEva's Receivables Turnover for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
ObsEva Receivables Turnover Related Terms
Thank you for viewing the detailed overview of ObsEva's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of innovative women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OBSEF has been successfully added to your 